Merrimack Pharmaceuticals, Inc. (MACK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:06PM EDT. Market open.
| Previous close | 15.00 |
| Open | 15.03 |
| Bid | 14.98 x 300 |
| Ask | 15.02 x 300 |
| Day's range | 15.00 - 15.03 |
| 52-week range | 11.53 - 15.89 |
| Volume | |
| Avg. volume | 143,356 |
| Market cap | 218.195M |
| Beta (5Y monthly) | 1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 13 Dec 2019 |
| 1y target est | N/A |
- Simply Wall St.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company
Key Insights Significantly high institutional ownership implies Merrimack Pharmaceuticals' stock price is sensitive to...
- Simply Wall St.
We're Interested To See How Merrimack Pharmaceuticals (NASDAQ:MACK) Uses Its Cash Hoard To Grow
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Simply Wall St.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) most popular amongst retail investors who own 39% of the shares, institutions hold 33%
Key Insights Significant control over Merrimack Pharmaceuticals by retail investors implies that the general public has...
© 2024 Yahoo. All rights reserved.